172 Results for "

Target ability

" in MedChemExpress (MCE) Product Catalog:
Products (172)

172 Results for "Target ability" in MCE Product Catalog:

Cat. No.: HY-183003C
Mannose-PEG5000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183003D
Mannose-PEG10000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183015
Mannose-PEG1000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183015A
Mannose-PEG2000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183015B
Mannose-PEG3400-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183015C
Mannose-PEG5000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183015D
Mannose-PEG10000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-P11921
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

FEAEHNLALQTL-GGGSC is a scrambled control peptide targeting the Glypican-3 (GPC3) polypeptide, with a GGGSC linker at its C-terminus. FEAEHNLALQTL-GGGSC serves as a negative control in both hepatoma cells and tumor-bearing mouse models, lacks specific targeting ability, and can be used for hepatocellular carcinoma-related research .
loading...
    loading...
Cat. No.: HY-P3196
CAS No.: 1673565-40-6
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

Tozuleristide is a tumor-targeting agent covalently conjugated to a derivative of the near-infrared fluorescent dye indocyanine green (ICG). Tozuleristide has the ability to penetrate the blood-brain barrier. Tozuleristide can be used in research related to fluorescence-guided surgery (FGS) .
loading...
    loading...
Cat. No.: HY-183163
Glucose-PEG1000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG1000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183163A
Glucose-PEG2000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG2000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183163B
Glucose-PEG3400-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG3400-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183163C
Glucose-PEG5000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG5000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183163D
Glucose-PEG10000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG10000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-P992314

Target:  

Integrin PD-1/PD-L1

Research Areas:  

Cancer

ASD141 is a mouse IgG1 antibody targeting mouse CD11b and a CD11b antagonist. ASD141 remodels the tumor microenvironment, enhances antigen presentation ability, and induces PD-L1 expression. ASD141 can be used for the research of colon cancer .
loading...
    loading...
Cat. No.: HY-172467
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG2000-CTT2 is a PEG compound which composed of DSPE and a gelatinase inhibitor (CTT2 (CTTHWGFTLC)). CTT2 (CTTHWGFTLC) has the ability to specifically target tumors. DSPE-PEG2000-CTT2 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-172466A
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG1000-CTT2 is a PEG compound which composed of DSPE and a gelatinase inhibitor (CTT2 (CTTHWGFTLC)). CTT2 (CTTHWGFTLC) has the ability to specifically target tumors. DSPE-PEG1000-CTT2 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-172468
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG5000-CTT2 is a PEG compound which composed of DSPE and a gelatinase inhibitor (CTT2 (CTTHWGFTLC)). CTT2 (CTTHWGFTLC) has the ability to specifically target tumors. DSPE-PEG5000-CTT2 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-183161
Synonyms: Glucose-PEG1000-Azide
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
loading...
    loading...
Cat. No.: HY-183161A
Synonyms: Glucose-PEG2000-Azide
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
loading...
    loading...